Your session is about to expire
← Back to Search
Aspirin + Celecoxib for Blood Pressure Control
Study Summary
This trial will test whether taking aspirin at the same time as celecoxib can help to lower blood pressure.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have not taken NSAIDs or stomach acid reducers in the last 2 weeks.You have had problems with drugs or alcohol in the past 6 months.I am over 18 years old.I haven't used tobacco or nicotine products for at least 3 months.Can understand and follow the instructions for the study.I am currently pregnant or breastfeeding.A BMI of 18-30 kg/m2 is considered normal weight.I am only taking medication for hormone replacement, thyroid, cholesterol, or blood pressure.I have taken blood thinners or anti-platelet medications before.I am in good health according to recent medical exams and tests.My high blood pressure is under control, with a diastolic reading of 100 mmHg or less.You are allergic to aspirin or other medications called NSAIDs.I am willing to provide a blood sample for genetic testing.I haven't taken supplements like Vitamin E or fish oil in the last 14 days.You are allergic to celecoxib (Celebrex) or aspirin.I haven't used tobacco or nicotine products for at least 3 months.I can avoid alcohol 48 hours before and during the study.Subjects must consent to provide a urine sample for drug and nicotine testing as part of the screening processOn average, does not consume more than one alcoholic beverage per day.I can avoid alcohol 48 hours before and during the study until the last visit.I have a history of stomach or intestinal problems, including ulcers.I am using birth control as a woman who can still have children.I have a blood disorder affecting clotting or bleeding.I haven't had cancer in the last 5 years, except for certain skin cancers or treated cervical cancer.I do not have a history of major heart, kidney, liver, lung (except old infections), immune, hormone, blood, or nerve diseases.
- Group 1: Aspirin 81 mg/Placebo
- Group 2: Celecoxib 200mg capsule
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many individuals are currently enrolled in the research?
"This research has stopped recruiting, with postings going up on December 1st 2022 and the final update being made in June 13th 2022. Nevertheless, there are still 845 clinical trials targeting healthy subjects (hs) as well as 206 studies for Aspirin 81 mg that require participants."
Are there any unfilled vacancies for participants in this research trial?
"Currently, this medical trial is not in a period of recruitment. Originally posted on December 1st 2022 and last updated June 13th 2021, the study has yet to open enrollment again. If you're searching for other trials, 845 studies are actively looking for participants with healthy subjects (HS) while 206 clinical trials are admitting enrollees into Aspirin 81 mg studies."
What conditions can be remedied with a daily dose of Aspirin 81 mg?
"Aspirin 81 mg is typically prescribed to aid with percutaneous coronary interventions (pci). It can also be used for other treatments such as relieving dental pain, reducing joint inflammation, and alleviating neck aches."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How responsive is this trial?
Typically responds via
Most responsive sites:
- Institute for Translational Medicine and Therapeutics (ITMAT), University of Pennsylvania: < 24 hours
Average response time
- < 1 Day
Share this study with friends
Copy Link
Messenger